Intuitive Surgical Stock Intrinsic Value – Learn How to Invest in Intuitive Surgical for Maximum Return
November 15, 2023
🌥️Trending News
Investing in Intuitive Surgical ($NASDAQ:ISRG) can be a great way to benefit from the growth of the medical industry. This revolutionary company is a leader in developing and manufacturing robotic technology for use in minimally invasive surgical procedures. Their advanced technology has allowed surgeons to perform complex procedures with greater precision and accuracy, resulting in better outcomes for patients with minimal recovery time. There are multiple options for investors to consider when looking to invest in Intuitive Surgical. Investing in the company’s stock is the most straightforward option and provides the potential for long-term gains when the stock rises.
Alternatively, investors can also purchase its bonds, which offer regular fixed payments, or look at alternative investments such as mutual funds or ETFs that have exposure to the company. It is important for all potential investors to thoroughly research Intuitive Surgical before investing. This means examining its financial results, observing its current stock price, and understanding the risks associated with any investment in the company. This will help investors make an informed decision and ensure they maximize their returns.
Price History
On Monday, INTUITIVE SURGICAL stock opened at $285.3 and closed at $282.5, representing an increase of 1.8% from the prior closing price of 277.5. This slight uptick in stock price is indicative that there are positive returns to be gained by investing in the company. With further research into the stock and its recent performance, investors can gain insight into the potential for future returns. Live Quote…
About the Company
Income Snapshot
Below shows the total revenue, net income and net margin for Intuitive Surgical. More…
| Total Revenues | Net Income | Net Margin |
| 6.85k | 1.52k | 22.1% |
Cash Flow Snapshot
Below shows the cash from operations, investing and financing for Intuitive Surgical. More…
| Operations | Investing | Financing |
| 2.02k | 1.26k | -1.22k |
Balance Sheet Snapshot
Below shows the total assets, liabilities and book value per share for Intuitive Surgical. More…
| Total Assets | Total Liabilities | Book Value Per Share |
| 14.71k | 2.09k | 35.61 |
Key Ratios Snapshot
Some of the financial key ratios for Intuitive Surgical are shown below. More…
| 3Y Rev Growth | 3Y Operating Profit Growth | Operating Margin |
| 16.7% | 17.9% | 24.7% |
| FCF Margin | ROE | ROA |
| 18.3% | 8.6% | 7.2% |
Analysis – Intuitive Surgical Stock Intrinsic Value
At GoodWhale, we conducted an in-depth analysis of INTUITIVE SURGICAL‘s fundamentals in order to gain insight into its intrinsic value. After careful consideration, our proprietary Valuation Line estimated INTUITIVE SURGICAL’s intrinsic value to be around $329.0. Currently, INTUITIVE SURGICAL stock is traded at $282.5, meaning that it is undervalued by 14.1%. This means that there is a great opportunity for investors to capitalize on this opportunity to purchase INTUITIVE SURGICAL shares at their current price and potentially gain a hefty return on their investment when the stock reaches its true, intrinsic value. More…
Peers
The company’s da Vinci surgical system consists of a surgeon’s console, a patient-side cart and a vision system. The company’s competitors in the robotic surgery market include Stryker Corp, Medtronic PLC, Becton, Dickinson and Co.
– Stryker Corp ($NYSE:SYK)
With a market capitalization of $84.98 billion as of 2022, Stryker Corporation is one of the world’s leading medical technology companies. Headquartered in Kalamazoo, Michigan, the company offers a broad range of products and services in orthopedics, medical and surgical, and neurotechnology and spine that help improve patient care and quality of life. The company’s products include implants used in hip, knee and shoulder replacements, as well as instrumentation and software used in operating rooms and for patient rehabilitation. In addition, Stryker offers a wide range of products and services for minimally invasive surgery, including robotic-assisted surgery systems. The company’s return on equity was 10.79% as of 2022.
– Medtronic PLC ($NYSE:MDT)
Medtronic PLC is a medical technology company that develops and produces a variety of medical devices and software products. The company has a market capitalization of 112.31 billion as of 2022 and a return on equity of 7.49%. Medtronic PLC’s products are used in a wide range of medical procedures, including cardiovascular, neurological, and orthopedic procedures. The company’s products are sold in over 150 countries around the world.
– Becton, Dickinson and Co ($NYSE:BDX)
Becton, Dickinson and Co is a medical technology company that manufactures and sells medical devices, laboratory equipment, and diagnostic products. The company has a market cap of 64.37B as of 2022 and a return on equity of 6.42%. The company’s products are used in a variety of medical procedures, including blood transfusions, IV start kits, and diabetes care.
Summary
Intuitive Surgical (ISRG) is an attractive stock for investors looking for long-term gains. Analysts suggest that the company is well-positioned to capitalize on the increasing demand for robotic and digital surgery technology. Fundamental analysis suggests that ISRG’s strong financial position, consistent revenue growth, and industry-leading technology will drive future growth.
The stock has a solid dividend yield, low volatility, and is expected to benefit from its exposure to the healthcare sector. Investors should consider ISRG as a potential buy-and-hold opportunity, as its innovative products are likely to remain in demand in the long term.
